GAM
TEVA icon

Grandview Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Grandview Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,800
Closed -$21K – 425
2021
Q1 		$21K Buy
+1,800
New +$20.6K 0.01% 278

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Grandview Asset Management's TEVA Position: Q2 2021 in Review

Grandview Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 1,800 shares — an estimated $21K sold.

Grandview Asset Management first reported a position in TEVA in Q1 2021 and held it in 1 quarter. The position peaked at $21K in Q1 2021. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Grandview Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Grandview Asset Management sold 1,800 Teva Pharmaceuticals shares in Q2 2021, an estimated $21K.
  • Grandview Asset Management first reported a position in Teva Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Grandview Asset Management's Teva Pharmaceuticals position peaked at $21K in Q1 2021.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.